Sabiscon Pharmaceuticals Private Limited
About Sabiscon Pharmaceuticals Private Limited
Data last updated:
Sabiscon Pharmaceuticals Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 13 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2019PTC109491.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vishwajeet Kumar Singh and Deepti Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Chandan Kumar Singh Flat A1 – 101 Building – A Om Complex, Surat, Gujarat, India – 394221.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.66 Lakh, a growth of 2% compared to the previous year. For the same year it recorded a net loss of ₹3,684 (net margin -0.6%) and EBITDA of ₹9,993 (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 17% over five years.
Company details
Contact details
Sabiscon Pharmaceuticals Private Limited's registered office is in Surat, Gujarat. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Chandan Kumar Singh Flat A1 – 101 Building – A Om Complex, Surat, Gujarat, India – 394221
- IndustryChemicals, Manufacturing, Basic Chemical
To see the full contact details of Sabiscon Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sabiscon Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sabiscon Pharmaceuticals Private Limited, buy the company report.
Financials of Sabiscon Pharmaceuticals Private Limited
FY 2025 filings availableSabiscon Pharmaceuticals Private Limited reported revenue of ₹6.66 Lakh (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 2% growth in the latest year. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9,993 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3,684 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | -0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sabiscon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sabiscon Pharmaceuticals Private Limited
Sabiscon Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishwajeet Kumar Singh | Director | 13 Aug 2019 | 7 Years 2 Months | Current |
| Deepti Kumari | Director | 13 Aug 2019 | 7 Years 2 Months | Current |
Peer comparison
Sabiscon Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stokem Pharmaceuticals Private Limited | ₹6.7 Lakh (FY 2025) | 2.0% | Purnia, Bihar, India | |||
| Aqutrus Pharmaceuticals Private Limited | ₹6.7 Lakh (FY 2021) | Ahmedabad, Gujarat, India | ||||
| Redan Pharmaceuticals Private Limited | ₹6.68 Lakh (FY 2018) | -12.0% | Chandigarh, India | |||
| Sabiscon Pharmaceuticals Private Limitedthis company | ₹6.66 Lakh (FY 2025) | -₹3,684 | -0.6% | 2.0% | Surat, Gujarat, India | |
| Tacaso Pharmaceuticals Private Limited | ₹6.65 Lakh (FY 2025) | 202.0% | Salem, Tamil Nadu, India | |||
| Zeltron Pharmaceuticals Private Limited | ₹6.65 Lakh (FY 2021) | -78.0% | Ahmedabad, Gujarat, India | |||
| Devank Pharmaceuticals Private Limited | ₹6.65 Lakh (FY 2024) | -31.0% | Gautam Buddh Nagar, Uttar Pradesh, India | |||
| Medwave Pharmaceuticals Private Limited | ₹6.64 Lakh (FY 2020) | 36.0% | Delhi, India |
To see the full peer comparison of Sabiscon Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sabiscon Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sabiscon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sabiscon Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sabiscon Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Deepti Kumari was appointed as Director on 13 Aug 2019.
Frequently asked questions
Sabiscon Pharmaceuticals is an active private limited company based in Surat, Gujarat, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 13 August 2019 (7+ years old) and is registered under CIN U24100GJ2019PTC109491.
Sabiscon Pharmaceuticals has 2 current directors:
- Vishwajeet Kumar Singh - Director
- Deepti Kumari - Director
The latest financial statements of Sabiscon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Sabiscon Pharmaceuticals is U24100GJ2019PTC109491. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sabiscon Pharmaceuticals was incorporated on 13 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Sabiscon Pharmaceuticals by revenue are Stokem Pharmaceuticals Private Limited, Aqutrus Pharmaceuticals Private Limited, Redan Pharmaceuticals Private Limited, Tacaso Pharmaceuticals Private Limited, Zeltron Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Deepti Kumari was appointed as Director on 13 Aug 2019. Vishwajeet Kumar Singh was appointed as Director on 13 Aug 2019.
The registered office of Sabiscon Pharmaceuticals is at CO Chandan Kumar Singh Flat A1 – 101 Building – A Om Complex, Surat, Gujarat, India – 394221.
Sabiscon Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Sabiscon Pharmaceuticals can be reached at its registered office: CO Chandan Kumar Singh Flat A1 – 101 Building – A Om Complex, Surat, Gujarat, India – 394221.
Sabiscon Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Ahmedabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
